PHS
ILMN icon

PFM Health Sciences’s Illumina ILMN Stock Holding History

PFM Health Sciences’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-572,802
Closed -$71.3M – 109
2016
Q4 		$71.3M Buy
+572,802
New +$77.2M 2.01% 19

Other funds holding ILMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's ILMN Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Illumina (ILMN) in Q1 2026: 28,869 shares worth $3.56M. The stake represents 0.32% of the portfolio and ranks #71 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in ILMN as recently as Q2 2015.

PFM Health Sciences first reported a position in ILMN in Q4 2013 and has held it in 5 quarters since. The position peaked at $69.6M in Q1 2015. 844 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • PFM Health Sciences held 28,869 shares of Illumina worth $3.56M as of Q1 2026.
  • Illumina was a new PFM Health Sciences position in Q1 2026.
  • Illumina made up 0.32% of PFM Health Sciences's portfolio in Q1 2026, its #71 holding.
  • PFM Health Sciences first reported a position in Illumina in Q4 2013 and has held it in 5 quarters since.
  • PFM Health Sciences's Illumina position peaked at $69.6M in Q1 2015.
  • 844 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.